Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT06779682

Systematic Screening for Obstructive Sleep Apnea During Preoperative Consultation Using AI-preoperative Agents

The goal of this observational study is to evaluate the feasibility of a systematic screening protocol for Obstructive Sleep Apnea (OSA) during preoperative anesthesia consultations in adults aged 50 and older undergoing elective surgery. The main questions it aims to answer are:

* Does the systematic screening protocol increase the proportion of patients identified as being at high risk for OSA compared to standard care? * What is the impact of systematic screening on postoperative outcomes, including complications, length of stay, and mortality?

Researchers will compare standard care practices (before implementation) to the systematic screening protocol (after implementation) to determine the effect on OSA detection rates and clinical outcomes.

Participants will:

* Complete the STOP-BANG questionnaire during their anesthesia consultation. * (Optional) Have a facial photograph taken to analyze morphometric characteristics that may correlate with OSA risk. * Be referred for further diagnostic testing if identified as high-risk for OSA.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Hopital Privé Claude Galien

Quincy-sous-Sénart, 91480, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • All patients with a national health identifier affiliated with the social security system, aged over 18, including French individuals over 50 years old, in scheduled anesthesia consultation with STOP BANG > 5 or > 4 with BMI > 35

Exclusion criteria

  • Refusal to participate in the study, age under 50, not affiliated with the social security system, minor or under legal protection

Treatment and study plan

Primary outcomes

  1. proportion of participants in whom the risk of OSA (Obstructive Sleep Apnea Syndrome) was detected in the control group before versus the group after

    Time frame: From enrollment to the end of treatment at 7 months

Secondary outcomes

  1. Mortality at 3 months.

    Time frame: From enrollment to the end of treatment at 7 months

  2. Postoperative length of stay.

    Time frame: From enrollment to the end of treatment at 7 months

  3. Sensitivity, specificity, and concordance rate of OSA (Obstructive Sleep Apnea Syndrome) detection.

    Time frame: From enrollment to the end of treatment at 7 months

  4. Correlation between facial morphotype and OSA diagnosis with and without facial morphotype measurement.

    Time frame: From enrollment to the end of treatment at 7 months

  5. Postoperative complications and mortality at 3 months.

    Time frame: From enrollment to the end of treatment at 7 months

  6. Postoperative complications

    Time frame: From enrollment to the end of treatment at 7 months

    Pulmonary event Cardiac event Kidney event Vascular event

Sponsors and collaborators

Lead sponsor

Intelligence Anesthesia

Industry

Collaborators

  • Department of Anesthesiology, Hopital Foch, Suresnes, France.
  • GCS Ramsay Santé pour l'Enseignement et la Recherche
  • Hôpital privé Claude Galien - Quincy-sous-Sénart

Registry information

Official study title

Feasibility Study: Systematic Screening for Obstructive Sleep Apnea (OSA) During Preoperative Consultation

Acronym: DASCA

Important dates

Study start
2024
Primary completion
2024
Study completion
2025
First posted
Jan 16, 2025
Registry last updated
Jan 17, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.